Buscar
Teva Pharmaceutical Industries Ltd
TEVAAñadir a la lista de seguimiento
39.810USD
-0.250-0.62%
Horarios del mercado 09/22, 11:21（ET）
46.38BCap. mercado
32.33P/E TTM
Acerca de {index_name} Teva Pharmaceutical Industries Ltd Compañía
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Perfil de Teva Pharmaceutical Industries Ltd
Símbolo de cotizaciónTEVA
Nombre de la empresaTeva Pharmaceutical Industries Ltd
Fecha de salida a bolsaFeb 06, 2087
Director ejecutivoFrancis (Richard D)
Número de empleados33892
Tipo de seguridadDepository Receipt
Fin del año fiscalFeb 06
Dirección124 Dvora Hanevi'a St.
CiudadTEL AVIV-YAFO
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísIsrael
Código postal6944020
Teléfono97239148213
Sitio Webhttps://www.tevapharm.com/
Símbolo de cotizaciónTEVA
Fecha de salida a bolsaFeb 06, 2087
Director ejecutivoFrancis (Richard D)
Ejecutivos de Teva Pharmaceutical Industries Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
2.12M
+0.68%
Mr. Richard D. Francis
Mr. Richard D. Francis
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.18M
+0.59%
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
885.93K
+11.77%
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
448.01K
+4.85%
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
183.56K
-16.34%
Dr. Eric A. Hughes
Dr. Eric A. Hughes
Executive Vice President - Global R&D, Chief Medical Officer
Executive Vice President - Global R&D, Chief Medical Officer
134.88K
+20.14%
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
130.15K
+11.13%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
130.04K
+33.98%
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
127.74K
+11.35%
Dr. Perry D. Nisen, M.D., Ph.D.
Dr. Perry D. Nisen, M.D., Ph.D.
Independent Director
Independent Director
119.81K
+12.10%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
2.12M
+0.68%
Mr. Richard D. Francis
Mr. Richard D. Francis
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.18M
+0.59%
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
885.93K
+11.77%
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
448.01K
+4.85%
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
183.56K
-16.34%
Dr. Eric A. Hughes
Dr. Eric A. Hughes
Executive Vice President - Global R&D, Chief Medical Officer
Executive Vice President - Global R&D, Chief Medical Officer
134.88K
+20.14%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Teva Pharmaceutical Industries Ltd?
Los cinco principales accionistas de Teva Pharmaceutical Industries Ltd son: Mr. Amir Elstein
¿Cuántas instituciones poseen acciones de Teva Pharmaceutical Industries Ltd (TEVA)?
A fecha de 2026Q1, 1226 instituciones poseen acciones de Teva Pharmaceutical Industries Ltd, con un valor de mercado combinado de aproximadamente 725.07M, lo que representa el 62.27% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 9191465.00.
¿Cuál es la mayor fuente de ganancias de Teva Pharmaceutical Industries Ltd?
El 2026Q1, el segmento empresarial Generic products generó la ganancia más alta para Teva Pharmaceutical Industries Ltd, ascendiendo a 2.10B y representando el 50.77% de la ganancia total.